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Etiology 
Sporotrichosis is caused by Sporothrix schenckii, a dimorphic fungus in the 
family Ophiostomataceae. S. schenckii is a yeast in tissues or in culture at 37
o
C, but 
grows as a filamentous mold at room temperature culture or in the environment. 
Geographic Distribution 
S. schenckii can be found worldwide. Sporotrichosis is particularly common in 
the tropics, where high humidity and temperatures promote fungal growth. In the 
U.S., this disease is seen most often in the southern coastal regions and Missouri and 
Mississippi river valleys. 
Transmission 
S. schenckii is present in soil, wood, and plants. It grows particularly well in soils 
rich in organic material. In warm environments with high humidity, it can also grow 
in plants and tree bark. Most cases of sporotrichosis are acquired from the 
environment, as a result of contact between broken skin and fungal spores. 
Penetrating wounds from dead vegetation and other items such as wood splinters, 
sphagnum moss, thorns, or hay are most likely to become infected. Bites, scratches, 
pecks, and stings from a variety of animals, birds, and insects can also inoculate the 
organism into wounds, via spores carried on the surface of the body. Rarely, 
inhalation can result in a pulmonary form of the disease. 
Sporotrichosis can also be transmitted from infected animals. In cats, skin lesions 
contain large numbers of organisms, which can be transmitted through cuts and 
abrasions. S. schenckii from cats may also be able to enter the body through intact or 
minimally damaged skin; zoonotic cases have been reported in people with no history 
of trauma at the inoculation site. In addition, the organisms can be found in the mouth 
and nasal cavity and on the nails of infected cats, facilitating transmission in bites and 
scratches. They also occur in the feces. Species other than cats can also spread 
sporotrichosis; however, the organisms are very sparse and transmission is much less 
likely. One case of person-to-person transmission, which occurred after frequent, 
close contact between a mother and her child, has been reported. 
Laboratory-acquired infections can result from direct contact with S. schenckii in 
fungal cultures or tissues. 
Disinfection 
Sporothrix schenckii is susceptible to a variety of disinfectants including 1% 
sodium hypochlorite, glutaraldehyde, iodine, phenolics, and formaldehyde. Its 
susceptibility to 70% ethanol is questionable. In addition, this organism can be 
inactivated by moist heat (121°C for 15 minutes or longer). 
S. schenckii survives readily outside the host. It may be found for months or 
years in soil, vegetation, wood, and other objects in the environment. 
Infections in Humans 
Incubation Period 
In humans, the incubation period is 1 week to 3 months. Most infections become 
apparent in approximately 3 weeks.  
Clinical Signs 
Cutaneous forms 
In humans, the most common form of sporotrichosis is the lymphocutaneous 
form. In this form, one or more papules appear first at the site of inoculation. These 
lesions can occur on any part of the body but often involve the extremities, 
particularly the hand or arm. The papules develop into pustules and then into slowly 
expanding subcutaneous nodules. The infection spreads along the lymphatics, 
forming a chain of subcutaneous nodules. The affected lymphatic vessels also become 
firm, thickened, and cordlike. As the infection progresses, the nodules become  
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necrotic, ulcerate, and may produce gray or yellowish 
pustular exudate. They are not tender unless secondary 
bacterial infection occurs. 
A fixed cutaneous form of sporotrichosis also occurs in 
humans. It is usually seen in geographic areas where 
sporotrichosis is endemic and people have a high degree of 
immunity. In this form, the skin lesions remain localized to 
one site and do not spread via the lymphatics. Most often, 
the lesions of the cutaneous form are found on the hands of 
adults and the faces of children.  
General health is not usually affected in the 
lymphocutaneous and fixed cutaneous forms. Untreated 
nodules can persist for months to years; while some authors 
feel that they never resolve, others suggest that some do. 
Asymptomatic infections may occur in some people who 
work with plants. 
Disseminated sporotrichosis and pulmonary 
sporotrichosis 
Two rare and potentially fatal forms, pulmonary and 
disseminated sporotrichosis, are also seen in humans. 
Disseminated disease most often affects the bones and 
joints, but many other organs including the mouth, nose, 
eyes, meninges, kidneys, liver, spleen, intestines, genitalia, 
or large areas of skin/ subcutaneous tissues can also be 
involved. In some cases, S. schenckii disseminates from 
cutaneous lesions; in others, disseminated disease occurs 
without cutaneous signs.  
Pulmonary sporotrichosis is caused by inhalation of the 
fungus. This form of sporotrichosis may be acute, but it is 
more often chronic and resembles tuberculosis. The 
symptoms may include cough, expectoration, dyspnea, 
pleuritic pain, hemoptysis, weight loss, and fatigue. The 
temperature may be slightly elevated. 
Communicability 
Open lesions contain organisms that could theoretically 
be transmitted to other people or animals; however, very 
few organisms are found in human lesions and only one 
case of person-to-person transmission has been reported. In 
the single documented case, the organism was transmitted 
from a lesion on a mother’s arm to her child’s face after 
frequent close contact. 
Diagnostic Tests 
In humans, sporotrichosis can be confirmed by fungal 
culture, direct visual observation of the organisms in 
lesions, or serology.  
S. schenckii can be cultured from sterile biopsies of 
lesions or from exudates. Sabouraud’s dextrose agar, brain-
heart infusion agar, or Emmon’s glucose-neopeptone agar 
can be used. On Sabouraud’s agar at room temperature, the 
mold colonies are initially off-white to black and become 
wrinkled and fuzzy. On blood agar at 37
o
C degrees, the 
yeast colonies are smooth and whitish. Culture takes 
approximately 1 to 3 weeks. Sporotrichosis can also be 
diagnosed by animal inoculation into mice or rats. 
In humans, S. schenckii is very difficult to detect in 
lesions using conventional staining methods. 
Immunofluorescent staining can occasionally find the 
organisms in biopsy samples, exudates, smears from sputum, 
or bronchial lavage. S. schenckii is a 1-2 µm x 3-8 µm, 
pleomorphic, round to cigar-shaped yeast in tissues. With 
conventional stains, it must be differentiated from other 
yeasts such as Candida spp, Histoplasma capsulatum, and 
Trichosporon spp. as well as the protozoan parasite 
Leishmania. 
Serologic tests used in humans include latex 
agglutination, immunodiffusion, and indirect immuno-
fluorescence. Serology is more helpful in disseminated 
disease than in the cutaneous forms. Antibodies are not 
always reliably present. 
Treatment 
Sporotrichosis is treated with antifungal drugs including 
itraconazole, ketoconazole, saperconazole, amphotericin B, 
and flucytosine. Potassium and sodium iodide are also used 
for the cutaneous and lymphocutaneous forms. 
Lymphocutaneous and cutaneous sporotrichosis almost 
always respond to treatment. Disseminated disease is more 
difficult to cure and requires long-term treatment. 
Debridement and repair may be necessary if the joints are 
involved. Lifelong therapy may be required in people with 
AIDS, to prevent recurrence. The pulmonary form is 
difficult to treat and, in addition to drugs, surgical resection 
may be attempted. 
Prevention 
Gloves should be worn while handling or treating 
affected animals, particularly cats. After the gloves are 
removed, the hands should be washed thoroughly and 
disinfected with chlorhexidine, povidone iodine, or another 
solution with antifungal activity. 
Protective clothing such as gloves, long-sleeved shirts, 
and long pants can decrease the risk of infection when 
working with rose bushes, hay bales, wires, conifer 
seedlings, or other plant material that can puncture the skin. 
Skin contact with sphagnum moss should also be avoided, 
as this material has been implicated in several outbreaks of 
sporotrichosis. 
Morbidity and Mortality 
Most cases of sporotrichosis occur in people who work 
with plants or contact infected cats. Most human cases are 
sporadic but outbreaks have also been described. Some 
outbreaks have been linked to contaminated sphagnum 
moss, hay, or wood. A zoonotic outbreak affecting 
approximately 500 people was associated with a feline 
epizootic in Rio de Janeiro, Brazil in 2002 and 2003. 
The most common form of sporotrichosis in humans, the 
lymphocutaneous form, usually remains localized to the skin 
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and is rarely life threatening. However, scarring, 
disfigurement, and bacterial superinfections are possible. 
There is also a slight risk that the disease might become 
disseminated or bacterial superinfections might cause sepsis.  
Disseminated sporotrichosis is a serious, potentially 
life-threatening disease with a grave prognosis. This form 
of sporotrichosis is rare; in one outbreak, it developed in 
only 5 of 3000 infected miners. Disseminated sporotrichosis 
appears to be more common in people with underlying 
conditions such as alcoholism, diabetes, cancer, or 
immunosuppression. Nevertheless, dissemination is 
uncommon even in AIDS patients.  
Pulmonary sporotrichosis is also rare. This disease 
tends to occur in people with preexisting lung diseases or 
alcoholism. It has not, to date, been reported as a zoonosis. 
Pulmonary sporotrichosis can be chronic and fatal, and 
responds poorly to treatment. 
Infections in Animals 
Species Affected 
Sporotrichosis occurs most often in horses. Cases have 
also been seen in cats, dogs, rodents, cattle, goats, swine, 
mules, camels, non-human primates, birds, and various wild 
animals including foxes, dolphins, and armadillos. 
Experimental infections have been established in many 
species including mice, rats, hamsters, guinea pigs, rabbits, 
cats, dogs, and monkeys.  
Incubation Period 
The incubation period in animals is probably similar to 
that of humans, occurring within 1 week to 3 months. 
In experimentally infected mice and hamsters, 
erythema and swelling appear within a week of inoculation. 
Small nodular lesions first become visible in approximately 
one week but become more apparent over the next few 
weeks.  
Clinical Signs 
Three forms of sporotrichosis –lymphocutaneous, 
cutaneous, and disseminated – are recognized in animals. In 
the lymphocutaneous (cutaneous-lymphatic) form, one or 
more firm round nodules occur first at the site of 
inoculation, and then spread along the lymphatics as a chain 
of nodules. The nodules and regional lymph nodes may 
ulcerate and drain purulent or serohemorrhagic exudate, and 
the lymphatics may become thickened, hard, and cordlike. 
Systemic illness is usually absent at first, but animals with 
chronic sporotrichosis may be febrile, depressed, and 
anorexic. Similar lesions occur in the cutaneous form, but 
they remain localized to one area. The cutaneous and 
lymphocutaneous forms may eventually disseminate to 
various deep tissues including the lung, bone, liver, spleen, 
kidneys, testes, gastrointestinal tract, and central nervous 
system. Some species differences have been noted. 
Equidae 
In horses and mules, sporotrichosis occurs most often 
on the lower limbs, particularly the fetlocks. The 
lymphocutaneous form is most common. The nodules may 
ulcerate and drain small amounts of exudate. They may also 
crust or form scabs, and can develop alopecic scars after 
healing. The lymphatics can become hard, swollen, and 
cordlike, and the affected limb may swell due to lymphatic 
stasis. The regional lymph nodes are rarely involved in 
horses, and disseminated disease has not been reported.  
Cats 
In cats, sporotrichosis varies from an asymptomatic 
infection to a fatal disseminated systemic disease. The 
initial lesions can be found anywhere but often develop on 
the distal extremities, base of the tail, or head. They begin 
as small, draining puncture wounds but eventually become 
nodular. These nodules may ulcerate or suppurate. Some 
ulcers may cavitate, exposing large areas of underlying 
muscle and bone. Although S. schenckii can spread along 
the lymphatics in cats, these vessels may not be obviously 
involved. Cats also spread the organisms to other parts of 
the body by grooming. Weight loss, anorexia, fever, 
depression, and dyspnea can occur if the lesions are 
extensive. In addition, the organisms can disseminate into 
the internal organs. Generalized or disseminated disease can 
be fatal. 
Dogs 
In dogs, sporotrichosis is typically a multinodular 
disease; the nodules resemble those seen in other species. 
The lesions often occur on trunk and head but may also be 
present on the limbs. Cording of lymphatics may be seen. In 
some cases, the lesions are found in the bones, liver, or 
lungs rather than the skin. 
Communicability 
Sporotrichosis in cats is a contagious disease; the skin 
lesions usually contain large numbers of organisms. S. 
schenckii can also be found in the mouth, nasal cavity, 
feces, and nails of infected cats. Shedding of organisms into 
the environment could theoretically increase the risk of 
pulmonary or disseminated disease in immunocompromised 
human companions. 
In other animal species, the lesions contain few 
organisms; nevertheless, all discharging lesions should be 
considered contagious.  
Diagnostic Tests 
In animals, sporotrichosis can be diagnosed by fungal 
culture or direct visual observation of the organisms in 
lesions or exudates. 
S. schenckii can be grown on Sabouraud’s dextrose agar, 
brain-heart infusion agar, or Emmon’s glucose-neopeptone 
agar. On Sabouraud’s agar at room temperature, the fungal 
colonies are initially off-white to black and become wrinkled 
and fuzzy. On blood agar at 37
o
C degrees, the yeast colonies 
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are smooth and whitish. Culture takes approximately 1 to 3 
weeks. Sporotrichosis can also be diagnosed by animal 
inoculation into mice or rats. 
Cytology sometimes reveals the characteristic 
organisms in exudates and skin or tissue biopsies. In most 
species including dogs and horses, S. schenckii is present in 
very small numbers and is difficult to detect with 
conventional staining methods. Immunofluorescent staining 
may be helpful but is not always successful. In cats, the 
yeasts are usually abundant in lesions and can be readily 
found with hematoxylin and eosin, or Wright’s stain. In 
tissues, S. schenckii is a 1-2 µm x 3-8 µm, pleomorphic, 
round to cigar-shaped yeast. With conventional staining 
methods, this organism must be differentiated from other 
yeasts such as Candida spp, Histoplasma capsulatum, and 
Trichosporon spp. as well as the protozoan parasite 
Leishmania. 
Treatment 
Various antifungal drugs including ketoconazole, 
itraconazole, and amphotericin B have been used to treat 
sporotrichosis in animals. Potassium or sodium iodide can 
be used in the cutaneous or lymphocutaneous forms. Cats 
are particularly sensitive to iodine and must be watched 
carefully for signs of toxicity when using these two drugs. 
In horses, single nodules are sometimes removed surgically. 
Prevention 
In animals, there is no practical way to prevent 
infections acquired from the environment. Infected animals, 
particularly cats, should be isolated to prevent the organism 
from spreading. Keeping cats indoors during feline 
epidemics can reduce the risk of infection; cat fights and 
other feline behaviors have been implicated in the spread of 
the disease. 
Morbidity and Mortality 
Sporotrichosis is most common in horses, less common 
in cats, and uncommon in dogs. In cats, it occurs most often 
in sexually intact males allowed to roam; however, cases 
have also been reported in indoor cats exposed only to 
houseplants and potting soil. Among dogs, this disease is 
seen most often in hunting dogs or other dogs frequently 
exposed to thorns and splinters. Most cases of 
sporotrichosis in animals are sporadic; however, an 
epidemic affecting more than a thousand cats was reported 
in Rio de Janeiro, Brazil in 2002/2003. Frequent cat fights 
and other feline behaviors are thought to have helped the 
organism spread in this epidemic. There was no association 
with FIV or FeLV-mediated immunosuppression.  
The risk of dissemination and fatal disease varies with 
the species. In horses, sporotrichosis is rarely fatal and 
disseminated disease has not been reported. In contrast, 
approximately half of all experimentally infected cats 
develop disseminated disease. Disseminated sporotrichosis 
is usually fatal without treatment. 
Post Mortem Lesions      Click to view images 
Granulomatous nodules are seen in the skin, and may 
occur in chains along lymphatic vessels. Exudation, 
ulceration, cavitation, crusting, scabbing, or scarring can 
occur. The lymphatics may be thickened and cordlike, and 
affected limbs may be edematous. 
In cats, the initial histologic lesion is perivascular 
dermatitis. Later, there is diffuse or nodular dermatitis; it 
may be suppurative, pyogranulomatous, or granulomatous. 
Intraepidermal microabscesses and pseudocarcinomatous 
epidermal hyperplasia may also be seen. Numerous yeasts 
are found in the lesions in cats but not in other species. In 
addition, most necropsies in affected cats reveal evidence of 
lymph node and lymphatic involvement. In cats with 
disseminated disease, small numbers of organisms may be 
found in internal organs. 
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/sporotric
hosis_g.htm 
Material Safety Data Sheets – Public Health Agency of 
Canada, Office of Laboratory Security 
http://www.phac-aspc.gc.ca/msds-ftss/index.html 
Medical Microbiology 
http://www.ncbi.nlm.nih.gov/books/NBK7627/ 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
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